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ABSTRACT 
Vaishvanara Churna is an Ayurvedic polyherbal formulation used traditionally as a Saraka 
(laxative), Shotaprasamana (anti-inflammatory) and for the treatment of Amavata (Rheumatoid 
Arthritis), management of Vibandha (Constipation), Udaravedana (abdominal pain), and 
Hridroga (heart disease). All the ingredients used in Ayurvedic formulations are of natural 
origin, owing to which the standardization of Ayurvedic formulations is difficult, which is the 
need of the hour. Vaishvanara Churna is one such Ayurvedic formulation. The Ayurvedic and 
other traditional systems of medicines are effective in curing several ailments, but the problem 
with them is they lack in satisfying quality assurance and quality control parameters, which help 
us recognize the quality of the formulation. Reliable clinical study data is not available, which 
thereby increases the scope of research in this area of medicine. 
This article aims at defining standards by comparing different marketed formulations and an in-
house formulation for the evaluation of Vaishvanara Churna. Our study basically intends to 
highlight the variations observed in marketed samples of Ayurveda formulations, using 
Vaishvanara Churna as an example. It is an unbiased study and have no intentions to claim 
anyone of the samples is superior to the other. 
The Churna was evaluated for its pharmacognostic, pharmaceutical and microbial parameters. 
The results obtained were within the limits prescribed by Ayurvedic Pharmacopoeia. 
KEYWORDS: Vaishvanara Churna, Ayurvedic, polyherbal, Rheumatoid Arthritis, laxative, 
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INTRODUCTION 
 Vaishvanara means Fire in Sanskrit. 
Vaishvanara Churna contains Saindhavalavana (Rock 
salt), Yamani (Trachyspermu mammi), Sunthi 
(Zingiber officinalis), Ajamoda (Apium leptophyllum), 
and Haritaki (Terminalia chebula). Vaishvanara 
Churna is used as a Saraka (laxative), 
Shotaprasamana (anti-inflammatory)[4] and for the 
treatment of Amavata (Rheumatoid Arthritis)[2,3,5]. It 
is also used in the management of Vibandha 
(Constipation), Udaravedana (abdominal pain), 
Hridroga (heart disease), Gulma (lump in the 
abdomen), Sula (pain), Pleeha (splenic disorder), 
Pachana (digestive)[2,3,5]. It is also recommended for 
use as Dipana (appetizer) and Vadanasamana 
(analgesic)[2,3,5].  
 Saindhavalavana is a composition of sodium 
chloride, traces of sodium bicarbonate, calcium 
sulfate, calcium chloride, and magnesium chloride. 
Saindhavalavana is traditionally used as an antiulcer, 
laxative, aphrodisiac, and antiseptic[1-6]. Yamani is 
popularly known as Ajowan. Fruits of Yamani are 
traditionally used as anti-inflammatory, laxative, 
diuretic, antiseptic, antispasmodic, tonic, carminative 
and stimulant. It is also effective in treating sore 
throat, bronchitis, diarrhea, and cholera[1-6]. Sunthi is 
used in treating motion sickness, nausea, vomiting, 
gastritis, diarrhea, indigestion, abdominal colic, 
intestinal parasites, arthritis, colds, influenza, 
bronchitis, flatulence, muscle spasms, food poisoning 
and certain heart conditions and also to promote 
perspiration, and digestive systems. Haritaki is 
commonly known as Chebulic myrobalam. Terminalia 
chebula is used in traditional medicines to treat 
constipation, kidney, and urinary disorders. It can 
also be used as a homeostatic, antitussive, diuretic, 
and ionotropic remedy. Altogether, Vaishvanara 
Churna shows significant laxative activity.[1-6] 
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DOSE: 5gm daily in divided doses can be taken along 
with buttermilk, ghee, warm water.[1] 
MATERIALS AND METHODS 
 All the ingredients obtained were of 
pharmacopoeial quality. Saindhavalavana was 
roasted at low temperature until free from moisture. 
The ingredients were powdered individually and 
were passed through sieve number 85. Each 
ingredient was weighed separately and mixed 
together in a specified ratio. The resulting mixture 
was passed through sieve number 44 to obtain a 
homogenous blend. The product was packed tightly 
to protect from light and moisture.[1] 
Pharmacognostic Evaluation 
 All the individual powdered raw ingredients 
and finished products were evaluated for their 
authenticity by pharmacognostic tests such as 
organoleptic evaluation and microscopic 
characteristics.[2,3] Representative samples of all the 
ingredients, marketed formulations and in-house 
formulations were exposed to an environment 
containing bleaching agent, phloroglucinol and 
concentrated hydrochloric acid and iodine. The 
resulting dispersion was mounted with glycerin on 
glass slide, for the purpose of microscopic evaluation. 
[1-3,5] 
Pharmaceutical Evaluation 
 For pharmaceutical evaluation[8] of the 
products, tests such as particle size, tap density, bulk 
density, angle of repose, Hausner’s Ratio, Carr’s 
Index, test for chloride, pH, loss on drying, alcohol 
soluble extractive value, water soluble extractive 
value, total ash, acid insoluble ash, Thin Layer 
Chromatography, and Sodium Flame Photometry 
were performed to standardize and compare the 
marketed and in-house polyherbal formulations.[3,8] 
Microbial Evaluation 
 The marketed and in-house formulations 
were evaluated for their microbial load. Media such 
as Nutrient agar media and Mac Conkey agar media 
were used for detecting microorganisms and E.coli 
respectively. The plates were incubated at 37oC for 
24-48 hours. Duplicates and control were 
maintained. 
Table 1 : Components of Marketed formulation 1, Marketed formulation 2 and In-house formulation of 
Vaishvanarachurna[1] 
Sr. no. Common name Scientific name Proportion 
1 Saindhavalavana Rock salt  2 parts 
2 Ajowain Trachyspermumammi 2 parts 
3 Ajmoda Apiumleptopyllum 3 parts 
4 Sunthi Zingiber officinalis 5 parts 
5 Haritaki Terminalia chebula 12 parts 
Table 2 : Test results of Marketed Formulation 1, Marketed Formulation 2 and In-house Formulation 
and Standards [1] 
Sr no. Tests Results Standards 
Marketed 
formulation 1 
Marketed 
formulation 2 
In-house 
formulation 
1 Particle size Fine powder Fine powder Fine powder - 
2 Tap density 0.52 gm/cc 0.66 gm/cc 0.62 gm/cc - 
3 Bulk density 0.3 gm/cc 0.4 gm/cc 0.3 gm/cc - 
4 Hausner’s ratio 1.73 1.65 2.06 - 
5 Carr’s index 73.33% 65% 106% - 
6 Angle of repose 33.0706o 26.75o 33.164o - 
7 Test for chloride Curdy white 
precipitate seen 
Curdy white 
precipitate seen 
Curdy white 
precipitate seen 
- 
8 Loss on drying 0.27% 0.37% 0.22% Not more than 10% 
9 Alcohol soluble 
extractive  
26.55% 17.45% 36.04% Not less than 34% 
10 Water soluble 
extractive 
88.64% 60.54% 47.53% Not less than 42% 
11 Total ash 14.68% 14.56% 13.48% Not more than 15% 
12 Acid insoluble ash 1.4% 1.2% 1.6% Not more than 1.8% 
13 Sodium flame 
photometry 
32 ppm 60 ppm 29 ppm Not less than 3% 
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Fig 1: Sclereids (Haritaki) Fig 2: Pitted Vessel (Haritaki)     Fig 3: Yellowish Brown Vittae (Ajmoda) 
 
 
 
 
 
 
 
 
 
 
 
Fig 4: Endosperm (Yavani)  Fig 5: Mesocarp (Ajmoda) Fig 6: Non Lignified Fiber (Ajmoda) 
 
 
 
 
 
 
 
 
 
 
Fig 7: Trichomes (Ajmoda) Fig 8: Starch Grains (Sunthi)  Fig 9: Endocarp (Haritaki) 
Spot Marketed Formulation 1 
(Rf Value) 
Marketed Formulation 2 
(Rf Value) 
In-house Formulation 
(Rf Value) 
Spot 1 0.125 0.106 0.087 
Spot 2 0.287 0.375 0.287 
Spot 3  0.487 0.487 
Spot 4 0.593 0.587 
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Table 3: Thin Layer Chromatography Results and Rf Values[1-3] of Marketed Formulation 1, Marketed 
Formulation 2 and In-house Formulation. Solvent System - Toluene: Ethyl acetate :: 5: 1 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
RESULTS AND DISCUSSIONS 
Pharmacognostic Evaluation of the marketed 
formulations and In-house formulation of 
Vaishvanara Churna showed brownish green colour, 
astringent taste, and characteristic aromatic odour. 
Microscopic Evaluation showed characteristics such 
as endocarp, mesocarp, endosperm, lignified and 
nonlignified fibres, sclereids, pitted vessels and 
oleoresin cells. On staining the sample with Iodine 
solution, starch crystals were observed[1-3,5]. Table 1 
indicates the components of all the three 
formulations and the ratios in which they are 
present[1,2]. Table 2 indicates the pharmaceutical tests 
performed on the Churnas and the results obtained, 
Standards as prescribed in the Ayurvedic 
Pharmacopoeia are also included[1-3]. Microbial Limit 
tests revealed microbial growth in the Nutrient Agar 
medium, indicating the presence of microbes in the 
formulation; however, the Mac Conkey Agar medium 
showed no microbial growth, indicating the absence 
of E.coli. Table 3 indicates the results obtained by 
performing Thin Layer Chromatography, by using 
Toluene: Ethyl acetate::5:1 as the solvent system[1,3,5]. 
In an overview, the pharmacognostic and 
pharmaceutical tests performed on Vaishvanara 
Churna yielded results which were well within the 
limits as prescribed in the Ayurvedic Pharmacopoeia. 
Fig 10: Marketed Formulation 1- Microbial 
growth seen in Nutrient Agar medium but 
absent in Mac Conkey medium. 
Fig 11: Marketed Formulation 2- 
Microbial growth seen in Nutrient Agar 
medium but absent in Mac Conkey 
medium. 
 
Fig 12: In-house Formulation- Microbial 
growth seen in Nutrient Agar medium but 
absent in Mac Conkey medium 
 
Fig 13: Control for Nutrient Agar 
medium and Mac Conkey medium 
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CONCLUSION 
The overall aim of drug standardization is to 
have uniformity, across the manufactures, with 
respect to its chemical and biological properties. 
Standardization methods should take into 
consideration all aspects contributing to the quality 
of the herbal drugs. The development of modern 
analytical tools in testing the various quality 
parameters for an effective quality control herbal 
product cannot be over emphasized. Standardization 
minimizes batch to batch variation; assure safety, 
efficacy, quality and acceptability of poly herbal 
formulations. The traditional approach towards 
standardization is insufficient for current herbal 
market and hence there is need for more advanced 
techniques for standardization. 
The main purpose of our study is to highlight 
and bring to notice the variations observed in 
marketed samples of Ayurveda formulations, using 
Vaishvanara Churna as an example of an Ayurvedic 
formulation. It is an unbiased study and have no 
intentions to claim anyone of the samples is superior 
to the other. Though there are several factors that 
make the standardization of Ayurveda formulation a 
great challenge, drastic variations within the same 
product will raise questions on the authenticity and 
credibility of the product. The need of the hour is 
better standardization protocols and quality 
measures for uniformity of formulations across the 
Ayurveda drug industry. In the era of globalization of 
Ayurveda, it is necessary to have utmost attention on 
the quality control parameters for the therapeutic 
formulations. Our observations are expected to open 
up discussions on the need of consistency and 
uniformity of formulations across the global 
Ayurvedic drug manufacturing industry. 
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